Beacon Capital Management, Inc. Amgen Inc Transaction History

Beacon Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $2,257 - $2,752	10 New	10 $2,000
Q4 2020 Jan 27, 2021	SELL	$216.38 - $257.67 $1,514 - $1,803	-7 Closed	0 $0
Q3 2020 Oct 07, 2020	BUY	$234.65 - $260.95 $1,642 - $1,826	7 New	7 $2,000
Q1 2018 Apr 04, 2018	SELL	$169.43 - $198.0 $847 - $990	-5 Closed	0 $0
Q4 2017 Jan 11, 2018	BUY	$168.79 - $188.59 $843 - $942	5	5 $1,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Beacon Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Beacon Capital Management, Inc. with notifications on news.